BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9784422)

  • 1. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines.
    Hofbauer LC; Dunstan CR; Spelsberg TC; Riggs BL; Khosla S
    Biochem Biophys Res Commun; 1998 Sep; 250(3):776-81. PubMed ID: 9784422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells.
    Brändström H; Björkman T; Ljunggren O
    Biochem Biophys Res Commun; 2001 Jan; 280(3):831-5. PubMed ID: 11162596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
    Viereck V; Emons G; Lauck V; Frosch KH; Blaschke S; Gründker C; Hofbauer LC
    Biochem Biophys Res Commun; 2002 Mar; 291(3):680-6. PubMed ID: 11855844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype.
    Varga F; Spitzer S; Klaushofer K
    Calcif Tissue Int; 2004 Apr; 74(4):382-7. PubMed ID: 15255076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.
    Hofbauer LC; Shui C; Riggs BL; Dunstan CR; Spelsberg TC; O'Brien T; Khosla S
    Biochem Biophys Res Commun; 2001 Jan; 280(1):334-9. PubMed ID: 11162519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha and -beta upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells.
    Brändström H; Jonsson KB; Vidal O; Ljunghall S; Ohlsson C; Ljunggren O
    Biochem Biophys Res Commun; 1998 Jul; 248(3):454-7. PubMed ID: 9703945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells.
    Vidal ON; Sjögren K; Eriksson BI; Ljunggren O; Ohlsson C
    Biochem Biophys Res Commun; 1998 Jul; 248(3):696-700. PubMed ID: 9703989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N; Maeda H; Yoshimine Y; Akamine A
    Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells.
    Makiishi-Shimobayashi C; Tsujimura T; Iwasaki T; Yamada N; Sugihara A; Okamura H; Hayashi S; Terada N
    Biochem Biophys Res Commun; 2001 Feb; 281(2):361-6. PubMed ID: 11181055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin in prostate cancer bone metastasis.
    Corey E; Brown LG; Kiefer JA; Quinn JE; Pitts TE; Blair JM; Vessella RL
    Cancer Res; 2005 Mar; 65(5):1710-8. PubMed ID: 15753366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
    Viereck V; Gründker C; Blaschke S; Frosch KH; Schoppet M; Emons G; Hofbauer LC
    J Cell Biochem; 2005 Dec; 96(6):1244-53. PubMed ID: 16152630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
    Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
    Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells.
    Chen Q; Kaji H; Kanatani M; Sugimoto T; Chihara K
    Horm Metab Res; 2004 Oct; 36(10):674-8. PubMed ID: 15523591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Co-expression of human bone morphogenetic protein-2 and osteoprotegerin in myoblast C2C12].
    Liu JZ; Hu YY; Ji ZL
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Jan; 17(1):1-4. PubMed ID: 12916296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis.
    Hofbauer LC; Gori F; Riggs BL; Lacey DL; Dunstan CR; Spelsberg TC; Khosla S
    Endocrinology; 1999 Oct; 140(10):4382-9. PubMed ID: 10499489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
    J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoprotegerin is expressed in colon carcinoma cells.
    Pettersen I; Bakkelund W; Smedsrød B; Sveinbjørnsson B
    Anticancer Res; 2005; 25(6B):3809-16. PubMed ID: 16309167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
    Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
    Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.
    Shipman CM; Croucher PI
    Cancer Res; 2003 Mar; 63(5):912-6. PubMed ID: 12615702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts.
    Tanabe N; Maeno M; Suzuki N; Fujisaki K; Tanaka H; Ogiso B; Ito K
    Life Sci; 2005 Jun; 77(6):615-26. PubMed ID: 15921993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.